MeaTech 3D Ltd. (NASDAQ:MITC), a technology company developing a suite of advanced manufacturing technologies to produce more environmentally friendly, cultured meat products, today announced it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) relating to methods that use purely plant-sourced inputs to guide targeted differentiation of embryonic mesenchymal stem cells (eMSCs) into adipocytes, which are fat cells. MeaTech's goal for the novel technology covered by this provisional patent application is to allow for production of intramuscular fat as is typically found in marbled meat like Wagyu beef.
MeaTech believes that this approach has the potential to enhance processes for cultivated fat production, whether as a stand-alone product or as a support for the Company's bioprinted structured meat technologies.
The filing of this provisional patent application represents another step forward in MeaTech's ongoing mission to develop technology with the potential to reduce the cost and complexity of cultured meat production. As the materials involved are all sourced from plants, the approach supports the Company's goal of using cell culturing media free of animal inputs.
Sharon Fima, CEO of MeaTech:
"The novel method covered by this provisional patent application employs 100% plant-sourced inputs to direct eMSC differentiation to fat cells. As we continue to work on developing and advancing technologies to produce cultivated fats and proteins, we are excited by the potential for using lower cost, plant-sourced cell-culturing inputs in hybrid as well as bioprinted products. Our ultimate goal is that eventually cultured grown meat will taste, feel, and be as nutritious as conventionally produced meat."